Enterovirus D68 Antivirals: Past, Present, and Future

被引:50
|
作者
Hu, Yanmei [1 ]
Musharrafieh, Rami [1 ]
Zheng, Madeleine [1 ]
Wang, Jun [1 ]
机构
[1] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
来源
ACS INFECTIOUS DISEASES | 2020年 / 6卷 / 07期
关键词
enterovirus D68; acute flaccid myelitis; antiviral;
D O I
10.1021/acsinfecdis.0c00120
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Enterovirus D68 (EV-D68) is an RNA virus that causes respiratory illnesses mainly in children. In severe cases, it can lead to neurological complications such as acute flaccid myelitis (AFM). EV-D68 belongs to the enterovirus genera of the Picornaviridae family, which also includes many other significant human pathogens such as poliovirus, enterovirus A71, and rhinovirus. There are currently no vaccines or antivirals against EV-D68. In this review, we present the current understanding of the link between EV-D68 and AFM, the mechanism of viral replication, and recent progress in developing EV-D68 antivirals by targeting various viral proteins and host factors that are essential for viral replication. The future directions of EV-D68 antiviral drug discovery and the criteria for drugs to reach clinical trials are also discussed.
引用
收藏
页码:1572 / 1586
页数:15
相关论文
共 50 条
  • [41] Pharmacological Characterization of the Mechanism of Action of R523062, a Promising Antiviral for Enterovirus D68
    Ma, Chunlong
    Hu, Yanmei
    Zhang, Jiantao
    Wang, Jun
    ACS INFECTIOUS DISEASES, 2020, 6 (08): : 2260 - 2270
  • [42] Acute flaccid myelitis caused by enterovirus D68: Case definitions for use in clinical practice
    Kramer, Rolf
    Lina, Bruno
    Shetty, Jay
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2019, 23 (02) : 235 - 239
  • [43] Pterostilbene, an active constituent of blueberries, enhances innate immune activation and restricts enterovirus D68 infection
    Yang, Qingran
    Li, Huili
    Li, Zhaoxue
    Yang, Jiaxin
    Zhang, Zhe
    Zhang, Lili
    Guo, Haoran
    Wei, Wei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [44] Neutralizing Enterovirus D68 Antibodies in Children after 2014 Outbreak, Kansas City, Missouri, USA
    Livingston, Robyn A.
    Harrison, Christopher J.
    Selvarangan, Rangaraj
    EMERGING INFECTIOUS DISEASES, 2022, 28 (03) : 539 - 547
  • [45] The role of conformational epitopes in the evolutionary divergence of enterovirus D68 clades: A bioinformatics-based study
    Fang, Yulu
    Chen, Qin
    Wang, Hui
    Wang, Liping
    Rong, Hao
    Liao, Qi
    Dong, Changzheng
    INFECTION GENETICS AND EVOLUTION, 2021, 93
  • [46] Acute flaccid myelitis; From poliovirus to enterovirus D68 and A71; Outbreaks and wastewater circulation
    Yelnik, Alain
    Levy-Bruhl, Daniel
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2024, 208 (09): : 1309 - 1316
  • [47] Functional and structural characterization of a two-MAb cocktail for delayed treatment of enterovirus D68 infections
    Zhang, Chao
    Xu, Cong
    Dai, Wenlong
    Wang, Yifan
    Liu, Zhi
    Zhang, Xueyang
    Wang, Xuesong
    Wang, Haikun
    Gong, Sitang
    Cong, Yao
    Huang, Zhong
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [48] Biennial Upsurge and Molecular Epidemiology of Enterovirus D68 Infection in New York, USA, 2014 to 2018
    Gilrane, Victoria L.
    Zhuge, Jian
    Huang, Weihua
    Nolan, Sheila M.
    Dhand, Abhay
    Yin, Changhong
    Salib, Christian
    Shakil, Faariah
    Engel, Helen
    Fallon, John T.
    Wang, Guiqing
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (09)
  • [49] Intra- and interpatient evolution of enterovirus D68 analyzed by whole-genome deep sequencing
    Dyrdak, Robert
    Mastafa, Monika
    Hodcroft, Emma B.
    Neher, Richard A.
    Albert, Jan
    VIRUS EVOLUTION, 2019, 5 (01)
  • [50] Neutralizing activity of intravenous immune globulin products against enterovirus D68 strains isolated in Japan
    Yoshida, Kazuhiro
    Muramatsu, Masamichi
    Shimizu, Hiroyuki
    BMC INFECTIOUS DISEASES, 2023, 23 (01)